Canada finalises guide on interpretation of significant changes to medical device
This article was originally published in RAJ Devices
Executive Summary
Health Canada has finalised changes to its guidance on the interpretation of significant changes to medium- and high-risk medical devices (Class III and IV) to help manufacturers decide whether the proposed changes require the submission of a licence amendment application prior to introducing the device on the market1.